At DNA Labs UAE, we are committed to providing advanced genetic testing services that cater to the specific needs of our clients. One of the critical tests we offer is the EGFR Gene EGFR Selective Sequencing of Exons 18-21 Genetic Test. This test is pivotal for individuals who are at risk or have been diagnosed with certain types of cancer, particularly non-small cell lung cancer (NSCLC). The EGFR gene plays a significant role in the development, growth, and spread of cancer cells. Mutations in specific exons of this gene, namely exons 18 to 21, are associated with sensitivity to targeted therapy, making this test crucial for personalized treatment plans.
Symptoms Indicating the Need for the EGFR Gene Test
Understanding the symptoms that may necessitate the EGFR gene test is essential for early detection and treatment. While the presence of these symptoms does not conclusively indicate a mutation in the EGFR gene, they can serve as critical indicators for further investigation:
- Persistent cough that does not improve with treatment
- Shortness of breath or difficulty breathing
- Chest pain
- Unexplained weight loss
- Hoarseness or change in voice
- Recurring infections like bronchitis or pneumonia
These symptoms are often mistaken for other less severe conditions, which makes the role of genetic testing even more significant. By identifying mutations in the EGFR gene, particularly in exons 18 to 21, healthcare providers can tailor treatment strategies that are more likely to be effective, improving patient outcomes.
About the EGFR Selective Sequencing of Exons 18-21 Genetic Test
The EGFR Selective Sequencing of Exons 18-21 Genetic Test offered by DNA Labs UAE is a sophisticated diagnostic tool designed to detect mutations in specific regions of the EGFR gene. This test is particularly beneficial for patients diagnosed with non-small cell lung cancer, as it helps in determining the most effective treatment protocol. The process involves the selective sequencing of exons 18 to 21 of the EGFR gene, which are the most common sites for mutations associated with cancer.
Benefits of the Test
- Enables personalized treatment plans by identifying specific mutations
- Helps in predicting the response to targeted therapies
- Can provide insights into the prognosis of the disease
- May assist in the identification of suitable candidates for clinical trials
Test Cost
The cost of the EGFR Gene EGFR Selective Sequencing of Exons 18-21 Genetic Test at DNA Labs UAE is 4400 AED. This cost is reflective of the comprehensive analysis and the detailed report provided, which includes actionable insights for healthcare providers. Understanding the financial aspect of genetic testing is crucial for patients and their families, and at DNA Labs UAE, we strive to offer transparent pricing for all our services.
Conclusion
The EGFR Gene EGFR Selective Sequencing of Exons 18-21 Genetic Test is a valuable tool in the management of certain types of cancer, particularly non-small cell lung cancer. By detecting mutations in specific exons of the EGFR gene, this test plays a crucial role in the development of personalized treatment plans, ultimately improving patient outcomes. If you or a loved one are experiencing symptoms associated with lung cancer or have been diagnosed with NSCLC, consider speaking with your healthcare provider about the benefits of this test.
For more information on the EGFR Gene EGFR Selective Sequencing of Exons 18-21 Genetic Test and other services offered by DNA Labs UAE, please visit our website.
